About AxoSim
AxoSim is a company based in New Orleans (United States) founded in 2014.. AxoSim has raised $6.78 million across 11 funding rounds from investors including NIH, TPG and HHS. The company has 27 employees as of December 31, 2022. AxoSim offers products and services including AxoSim Platform and Products. AxoSim operates in a competitive market with competitors including Emulate, CN Bio, Mimetas, Nortis and NETRI, among others.
- Headquarter New Orleans, United States
- Employees 27 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Axosim, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.78 M (USD)
in 11 rounds
-
Latest Funding Round
$3.68 M (USD), Series A
Nov 08, 2024
-
Investors
NIH
& 6 more
-
Employee Count
27
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AxoSim
AxoSim offers a comprehensive portfolio of products and services, including AxoSim Platform and Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for building and studying human brain models in labs.
Resources for addressing neurological disorders through lab innovation.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of AxoSim
AxoSim has successfully raised a total of $6.78M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $3.68 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series A — $3.7M
-
First Round
First Round
(01 Feb 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series A - AxoSim | Valuation |
investors |
|
| Sep, 2020 | Amount | Grant - AxoSim | Valuation |
investors |
|
| Jun, 2020 | Amount | Seed - AxoSim | Valuation | Benson Capital Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AxoSim
AxoSim has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, TPG and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Jefferson Capital Partners is engaged in providing growth capital solutions.
|
Founded Year | Domain | Location | |
|
A 4-month acceleration program for technology startups is provided.
|
Founded Year | Domain | Location | |
|
Fund of funds focused on pre-seed and seed-stage companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AxoSim
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AxoSim
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Axosim Comparisons
Competitors of AxoSim
AxoSim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, Mimetas, Nortis and NETRI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of in vitro models for drug development
|
|
| domain | founded_year | HQ Location |
Organ-on-a-chip platforms are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based organ-on-a-chip models for drug evaluation are developed.
|
|
| domain | founded_year | HQ Location |
Small human tissue segments are generated in microfluidic chips.
|
|
| domain | founded_year | HQ Location |
Microfluidic devices are developed for industrial applications and brain-on-a-chip models.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Axosim
Frequently Asked Questions about AxoSim
When was AxoSim founded?
AxoSim was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is AxoSim located?
AxoSim is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
Is AxoSim a funded company?
AxoSim is a funded company, having raised a total of $6.78M across 11 funding rounds to date. The company's 1st funding round was a Seed of $1.97M, raised on Feb 01, 2016.
How many employees does AxoSim have?
As of Dec 31, 2022, the latest employee count at AxoSim is 27.
What does AxoSim do?
AxoSim was founded in 2014 in New Orleans, United States, with a focus on biotechnology. Nerve-on-a-chip technology, a 3D cell-based model mimicking nerve functions, was developed in Dr. Michael J. Moores lab at Tulane University. Funding has been received from the National Science Foundations Innovation Corps program. Operations center on creating these models to support drug testing and development processes in the biotech sector.
Who are the top competitors of AxoSim?
AxoSim's top competitors include Emulate, CN Bio and Cellbox Labs.
What products or services does AxoSim offer?
AxoSim offers AxoSim Platform and Products.
Who are AxoSim's investors?
AxoSim has 7 investors. Key investors include NIH, TPG, HHS, The Idea Village, and Benson Capital Partners.